Clinical Trial: A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma
Study Status: Completed
Recruit Status: RECRUITING
Condition: Mantle Cell Lymphoma
Study Type: INTERVENTIONAL
Official Title: Phase 2 Study of Tafasitamab and Lenalidomide in Relapsed or Refractory Mantle Cell Lymphoma
Brief Summary:
The purpose of this study is to determine if the combination of tafasitamab and lenalidomide is an effective treatment for relapsed or refractory Mantle Cell Lymphoma.
Read more